Staging and prognosis in lung cancer: making the complex accessible.
Langer
C J
CJ
Fox Chase Cancer Center Philadelphia, PA 19111, USA.
D000230:Adenocarcinoma / Q000235:genetics / Q000401:mortality / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018287:Carcinoma, Large Cell / Q000401:mortality / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000145:classification / Q000235:genetics / Q000401:mortality / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D003952:Diagnostic Imaging; D003955:Diagnostic Tests, Routine; D005260:Female; D011905:Genes, ras; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D008207:Lymphatic Metastasis; D008297:Male; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000235:genetics; D009367:Neoplasm Staging / Q000379:methods; D010808:Physical Examination; D016066:Pleural Effusion, Malignant / Q000453:epidemiology; D011013:Pneumonectomy; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012008:Recurrence; D015996:Survival Rate; D019098:Telomerase / Q000235:genetics
D009363:Neoplasm Proteins; D019098:Telomerase